̽»¨ºÏ¼¯

Summary: API-sparing development techniques and identification of the appropriate scalable formulation technology to improve drug solubility and enhance oral bioavailability.

Summary: In this webinar, an academic expert will discuss optimal design space parameters involved in developing spray dried dispersion of poorly soluble drugs for oral and vaccine delivery.

Summary: ̽»¨ºÏ¼¯ CEO Johh Chiminski discusses how the pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19.

Summary: This webinar aims to provide clarity on the types of molecules suitable for an ODT format as well as the regulatory pathways for new and established therapies.

Summary: This webinar provides an overview of co-amorphous research and its recent findings, particularly, the impact of low molecular weight excipient on developability, stability and solubility.

Summary: Learn about the current challenges in pediatric drug development programs including predicting oral absorption, and in vitro and in silico methods that can be applied to predict behavior in pediatric populations.

Summary: In this webinar, ̽»¨ºÏ¼¯ experts will explain how the phase appropriate expertise and technologies of the OneXpress® Solution can help streamline development and manufacturing, speed up your program timelines and reduce risks to transform your science into a successful treatment.

Summary: In this webinar, we explain why a lipid drug development platform can meet the need for speed to clinic and how the innovative lipid excipients and technologies could solve formulation challenges, optimizing bioavailability for early phase molecules, improve patient compliance and bring products faster to market.

Summary: Three early drug development experts present insights and techniques to help your clients get their molecules from preclinical to Phase 1 studies.

Summary: Phase-appropriate CMC-related activities can facilitate the transition from early development through commercialization.